Clinical Trial Update: Hair-sparing Whole Brain Radiotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hair-sparing whole brain radiotherapy for brain metastases due to small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Ghent | Conditions: Brain Metastases, Small Cell Lung Cancer | Phase 2 | Status: TERMINATED